C Horton

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

R Powles, Jayesh Mehta, Samar Kulkarni et al. · The Lancet · 2000 · 355 citations

Transplantation, Marrow Transplantation, Medicine +12

Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants

Samar Kulkarni, R Powles, Jennie Treleaven et al. · Blood · 2000 · 149 citations

Identification of Patients Who May Benefit From Prophylactic Immunotherapy After Bone Marrow Transplantation for Acute Myeloid Leukemia on the Basis of Lymphocyte Recovery Early After Transplantation

R Powles, Seema Singhal, Jennifer Treleaven et al. · Blood · 1998 · 124 citations · Full text

The role of autologous transplantation in patients with multiple myeloma aged 65 years and over

Bhawna Sirohi, R Powles, J Treleaven et al. · Bone Marrow Transplantation · 2000 · 115 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +10

A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106 CD34+ cells/kg be considered the minimum threshold?

Seema Singhal, R Powles, J Treleaven et al. · Bone Marrow Transplantation · 2000 · 110 citations

Hematological Malignancy, Transplantation, Cd34+ Cells/kg +6